Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy.
暂无分享,去创建一个
S. Jagannath | A. Deisseroth | F. Dunphy | G. Spitzer | K. Dicke | L. Souza | K. Taylor | S. Huan | G. Ventura | B. Fogel